- ISIN DE000A37FT41
- Country Deutschland
Latest Research
News Functions
Additional Functions
25 August 2020
Epigenomics AG
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): Kaufen
16 April 2018
Epigenomics AG
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): Buy
19 December 2017
Epigenomics AG
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): BUY
6 October 2017
Epigenomics AG
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): BUY
21 April 2011
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Langfr. Kaufen
15 November 2010
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Langfristig Kaufen
16 August 2010
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Kaufen
22 April 2010
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Kaufen
19 March 2010
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Kaufen
20 January 2010
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Halten
22 December 2009
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Kaufen
16 November 2009
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Kaufen
7 October 2009
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Kaufen
13 August 2009
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Kaufen
14 May 2009
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Kaufen
28 September 2007
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Kaufen
16 August 2007
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): spekulativ Kaufen
14 May 2007
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Spekulativ Kaufen
16 April 2007
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Spekulativ Kaufen
13 December 2006
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Kaufen
Latest News
News Functions
Additional Functions
10 April 2024
Epigenomics AG
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
14 March 2024
Epigenomics AG
Epigenomics AG publishes financial results for fiscal year 2023
12 March 2024
Epigenomics AG
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
6 March 2024
Epigenomics AG
15 February 2024
Epigenomics AG
Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet
31 January 2024
Epigenomics AG
Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board
Upcoming Events
Event Functions
Additional Functions
Latest Reports
News Functions
Additional Functions
14 March 2024
Epigenomics AG
Jahresabschluss 2023
10 August 2023
Epigenomics AG
Halbjahresfinanzbericht 2023
31 May 2023
Epigenomics AG
Q1 statement / Q1 financial report 2023
28 April 2023
Epigenomics AG
Jahresfinanzbericht 2022
Epigenomics AG
Annual financial report 2022